Mesoblast director Gregory reports warrant holdings
Mesoblast Ltd director George Gregory filed an initial Form 3 detailing his derivative holdings in MESO.
Rhea-AI Filing Summary
Mesoblast Ltd director George Gregory filed an initial Form 3 detailing his derivative holdings in MESO. The filing lists indirect warrants over 6,830,602 ordinary shares at an exercise price of $2.86 expiring in 2028, plus direct warrants over 200,000 ADS at $9.06 and 1,600,000 ordinary shares or ADS at $2.50 expiring between 2028 and 2029.
He also holds three option tranches over 66,667, 66,667 and 66,666 ordinary shares at $1.72 per share, which become exercisable between 2026 and 2028 and expire in 2032. The Form 3 reports these existing positions and does not show new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrants | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does George Gregory’s Form 3 for MESOBLAST (MESO) show?
Does George Gregory’s MESOBLAST Form 3 indicate insider buying or selling?
How are George Gregory’s MESOBLAST warrants held directly vs. indirectly?
AI-generated analysis. How Rhea-AI works. Not financial advice.